Historical Valuation
Xtant Medical Holdings Inc (XTNT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.91 is considered Fairly compared with the five-year average of -14.57. The fair price of Xtant Medical Holdings Inc (XTNT) is between 0.34 to 1.21 according to relative valuation methord.
Relative Value
Fair Zone
0.34-1.21
Current Price：0.70
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Xtant Medical Holdings Inc (XTNT) has a current Price-to-Book (P/B) ratio of 2.08. Compared to its 3-year average P/B ratio of 2.23 , the current P/B ratio is approximately -7.04% higher. Relative to its 5-year average P/B ratio of 2.77, the current P/B ratio is about -25.16% higher. Xtant Medical Holdings Inc (XTNT) has a Forward Free Cash Flow (FCF) yield of approximately 4.95%. Compared to its 3-year average FCF yield of -11.62%, the current FCF yield is approximately -142.58% lower. Relative to its 5-year average FCF yield of -8.12% , the current FCF yield is about -160.93% lower.
P/B
Median3y
2.23
Median5y
2.77
FCF Yield
Median3y
-11.62
Median5y
-8.12
Competitors Valuation Multiple
AI Analysis for XTNT
The average P/S ratio for XTNT competitors is 0.79, providing a benchmark for relative valuation. Xtant Medical Holdings Inc Corp (XTNT.A) exhibits a P/S ratio of 0.91, which is 15.01% above the industry average. Given its robust revenue growth of 19.04%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for XTNT
1Y
3Y
5Y
Market capitalization of XTNT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of XTNT in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is XTNT currently overvalued or undervalued?
Xtant Medical Holdings Inc (XTNT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.91 is considered Fairly compared with the five-year average of -14.57. The fair price of Xtant Medical Holdings Inc (XTNT) is between 0.34 to 1.21 according to relative valuation methord.
What is Xtant Medical Holdings Inc (XTNT) fair value?
XTNT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Xtant Medical Holdings Inc (XTNT) is between 0.34 to 1.21 according to relative valuation methord.
How does XTNT's valuation metrics compare to the industry average?
The average P/S ratio for XTNT's competitors is 0.79, providing a benchmark for relative valuation. Xtant Medical Holdings Inc Corp (XTNT) exhibits a P/S ratio of 0.91, which is 15.01% above the industry average. Given its robust revenue growth of 19.04%, this premium appears unsustainable.
What is the current P/B ratio for Xtant Medical Holdings Inc (XTNT) as of Jan 09 2026?
As of Jan 09 2026, Xtant Medical Holdings Inc (XTNT) has a P/B ratio of 2.08. This indicates that the market values XTNT at 2.08 times its book value.
What is the current FCF Yield for Xtant Medical Holdings Inc (XTNT) as of Jan 09 2026?
As of Jan 09 2026, Xtant Medical Holdings Inc (XTNT) has a FCF Yield of 4.95%. This means that for every dollar of Xtant Medical Holdings Inc’s market capitalization, the company generates 4.95 cents in free cash flow.
What is the current Forward P/E ratio for Xtant Medical Holdings Inc (XTNT) as of Jan 09 2026?
As of Jan 09 2026, Xtant Medical Holdings Inc (XTNT) has a Forward P/E ratio of -149.40. This means the market is willing to pay $-149.40 for every dollar of Xtant Medical Holdings Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Xtant Medical Holdings Inc (XTNT) as of Jan 09 2026?
As of Jan 09 2026, Xtant Medical Holdings Inc (XTNT) has a Forward P/S ratio of 0.91. This means the market is valuing XTNT at $0.91 for every dollar of expected revenue over the next 12 months.